Experimental evaluation demonstrates Febuxostat boosts photodynamic therapy effectiveness in bladder cancer, suggesting a novel therapeutic strategy for clinical trials.
These results indicate that Febuxostat effectively potentiates the photodynamic effects of ALA in bladder cancer cells, promising a novel therapeutic strategy that warrants further exploration in preclinical models and potential clinical trials.
No takes yet. Share an insight, caveat, or question.
Khatami et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: